Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

Pembrolizumab new option for firstline treatment of advanced lung cancer with...

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Pembrolizumab new option for firstline treatment of advanced lung cancer with high PDL-1 expression ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )

Pembrolizumab plus chemo as firstline therapy for NSCLC

Dr Corey Langer - University of Pennsylvania, Philadelphia, USA

Pembrolizumab plus chemo as firstline therapy for NSCLC ( Dr Corey Langer - University of Pennsylvania, Philadelphia, USA )

ASCEND-5: Ceritinib for ALK positive NSCLC previously treated with crizotinib

Dr Giorgio Scagliotti - University of Turin, Turin, Italy

ASCEND-5: Ceritinib for ALK positive NSCLC previously treated with crizotinib ( Dr Giorgio Scagliotti - University of Turin, Turin, Italy )

Pembrolizumab 'should be first line treatment' for high PD1 expressing NSCLC...

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Pembrolizumab 'should be first line treatment' for high PD1 expressing NSCLC patients ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )

Firstline pembrolizumab plus chemo improves NSCLC outcomes

Dr Corey Langer - University of Pennsylvania, Philadelphia, USA

Firstline pembrolizumab plus chemo improves NSCLC outcomes ( Dr Corey Langer - University of Pennsylvania, Philadelphia, USA )

Immunotherapy and treatment advances in small cell lung cancer

Prof Dean Fennell - University of Leicester, Leicester, UK

Immunotherapy and treatment advances in small cell lung cancer ( Prof Dean Fennell - University of Leicester, Leicester, UK )

Lung cancer screening in the UK

Prof John Field - University of Liverpool, Liverpool, UK

Lung cancer screening in the UK ( Prof John Field - University of Liverpool, Liverpool, UK )

Screening, surgical cure and new developments: Future smart surgical approaches...

Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan...

Screening, surgical cure and new developments: Future smart surgical approaches for brain mets ( Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy )

ALK mutations in paediatric tumours

Dr Suzanne Turner - Cambridge University, Cambridge, UK

ALK mutations in paediatric tumours ( Dr Suzanne Turner - Cambridge University, Cambridge, UK )

NSCLC biology and new therapies: Reversing resistance

Prof Michael Seckl - Imperial College London, London, UK

NSCLC biology and new therapies: Reversing resistance ( Prof Michael Seckl - Imperial College London, London, UK )

NSCLC biology and new therapies: Immunotherapies

Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain

NSCLC biology and new therapies: Immunotherapies ( Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain )

NSCLC biology and new therapies: Animal models of lung cancer

Prof Julian Downward - The Francis Crick Institute, London, UK

NSCLC biology and new therapies: Animal models of lung cancer ( Prof Julian Downward - The Francis Crick Institute, London, UK )

More from ecancer